Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine.
about
An alternative splicing form of phosphatidylserine-specific phospholipase A1 that exhibits lysophosphatidylserine-specific lysophospholipase activity in humansSurfactant phospholipid metabolismDietary fat and prostate cancer: current status.Combinatory Evaluation of Transcriptome and Metabolome Profiles of Low Temperature-induced Resistant Ascites Syndrome in Broiler Chickens.Diminished expression of transcription factors nuclear factor kappaB and CCAAT/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice.The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene.Modulation of nitric oxide synthase activity in macrophages.Insights into thymic involution in tumor-bearing mice.Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1.Structural requirements for selective binding of ISC1 to anionic phospholipids.Functional analysis of Chinese hamster phosphatidylserine synthase 1 through systematic alanine mutagenesis.Crotamine stimulates phagocytic activity by inducing nitric oxide and TNF-α via p38 and NFκ-B signaling in RAW 264.7 macrophages.A novel phosphatidylserine-binding peptide motif defined by an anti-idiotypic monoclonal antibody. Localization of phosphatidylserine-specific binding sites on protein kinase C and phosphatidylserine decarboxylase.Purification and characterization of Chinese hamster phosphatidylserine synthase 2.Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide.
P2860
Q22009159-A168FACE-765E-41CB-B2B0-2069428A59C0Q26826812-F054A525-B350-41DE-84BF-B63A86F5A493Q33539814-8D2876BB-01E9-4DCD-A2D0-91CE0C323CDEQ33725665-3618F51B-5EE0-4CD2-8BCA-73955E8D1022Q34235522-333433D0-1042-4053-A46A-E6C4FC1F5A04Q36366553-C49C2784-4C25-4B74-91D6-C7BD155E3FC0Q37162178-6B62BF76-401E-4058-9B76-580CA86C4D6CQ38160402-B951FE7F-67D4-4902-A24D-CD237A9C9E95Q38162151-16CB7984-BE8F-4532-815C-5A31098C2556Q38362771-8D11490B-37F0-4227-88BB-8C5F856093AEQ40558597-FE01708A-C043-489F-894E-FA1C7E114824Q42586119-FCC39F4A-FC68-4527-B982-CB9ABDA5C54DQ42672916-58A4B24A-103A-4A09-81EA-FEC4D36CE656Q44545614-F96BAA0E-6504-4FD2-B68F-8929B90211ABQ48017762-52248A16-CF27-4829-AD20-62EAD94C22EB
P2860
Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Isolation of a nitric oxide in ...... zation as phosphatidyl serine.
@ast
Isolation of a nitric oxide in ...... zation as phosphatidyl serine.
@en
type
label
Isolation of a nitric oxide in ...... zation as phosphatidyl serine.
@ast
Isolation of a nitric oxide in ...... zation as phosphatidyl serine.
@en
prefLabel
Isolation of a nitric oxide in ...... zation as phosphatidyl serine.
@ast
Isolation of a nitric oxide in ...... zation as phosphatidyl serine.
@en
P2093
P2860
P356
P1476
Isolation of a nitric oxide in ...... zation as phosphatidyl serine.
@en
P2093
C Calderón
E M Sotomayor
P2860
P304
P356
10.1084/JEM.180.3.945
P407
P577
1994-09-01T00:00:00Z